ArrowMark Colorado Holdings’s Rhythm Pharmaceuticals RYTM Stock Holding History

ArrowMark Colorado Holdings’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-543,990	Closed	-$11.7M	–	323
2019 Q3	$11.7M	Buy	543,990 +7,817	+1%	+$168K	0.12%	144
2019 Q2	$11.8M	Sell	536,173 -3,218	-0.6%	-$81.3K	0.11%	154
2019 Q1	$14.8M	Buy	539,391 +24,518	+5%	+$705K	0.14%	134
2018 Q4	$13.8M	Buy	514,873 +25,930	+5%	+$717K	0.15%	137
2018 Q3	$14.3M	Sell	488,943 -10,569	-2%	-$334K	0.12%	161
2018 Q2	$15.6M	Buy	499,512 +16,748	+3%	+$458K	0.14%	144
2018 Q1	$9.61M	Buy	482,764 +18,655	+4%	+$495K	0.1%	184
2017 Q4	$13.5M	Buy	+464,109	New	+$12.3M	0.14%	145

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ArrowMark Colorado Holdings's RYTM Position: Q4 2019 in Review

ArrowMark Colorado Holdings sold out of Rhythm Pharmaceuticals (RYTM) in Q4 2019, closing a stake of 543,990 shares — an estimated $11.7M sold.

ArrowMark Colorado Holdings first reported a position in RYTM in Q4 2017 and held it in 8 quarters. The position peaked at $15.6M in Q2 2018. 89 funds tracked by Wall St. Rank hold RYTM as of Q4 2019.

ArrowMark Colorado Holdings reported no remaining Rhythm Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
ArrowMark Colorado Holdings sold 543,990 Rhythm Pharmaceuticals shares in Q4 2019, an estimated $11.7M.
ArrowMark Colorado Holdings first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 8 quarters.
ArrowMark Colorado Holdings's Rhythm Pharmaceuticals position peaked at $15.6M in Q2 2018.
89 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q4 2019.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.